ArticleClinical rheumatology2025
Risk prediction model for psoriatic arthritis: NHANES data and multi-algorithm approach.
Article in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Explainable machine learning revealing the impact of mental and physical health on arthritis.BMJ health & care informatics · 2026Article
- Psoriatic Arthritis: Developments in 2025.Mediterranean journal of rheumatology · 2026Review
- Development of a machine learning-based risk prediction model for early-stage pneumoconiosis: a retrospective study.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop a simplified predictive model for identifying psoriatic arthritis (PsA) in psoriasis patients.
methodsData from the National Health and Nutrition Examination Survey (NHANES) database were analyzed, including patients with psoriasis without arthritis (PsC) or PsA. The least absolute shrinkage and selection operator, Boruta algorithm, random forest, and stepwise regression were employed to select key variables from 38 potential predictors. Logistic regression models were constructed for each combination of selected variables and evaluated using receiver operating characteristic (ROC) curves, precision-recall (PR) curves, calibration plots, Brier scores, and decision curve analysis (DCA).
resultsThe study included 587 patients with psoriasis, 238 of whom had PsA. The variable combinations proposed by the Boruta algorithm exhibited the best overall performance. Key predictors in the Borutamodel included age, fasting glucose, education level, thyroid disease, hypertension, and chronic bronchitis. This model achieved area under the curve (AUC) of 0.781 (95% CI, 0.737-0.826) for the training set and 0.780 (95% CI, 0.712-0.848) for the testing set in the ROC curve analyses. The AUC values in the PR curves were 0.687 (95% CI, 0.611-0.757) and 0.653 (95% CI, 0.535-0.770), respectively. The Brier scores of 0.186 and 0.191 for the testing and training sets indicated a good fit, further supported by the calibration curves. DCA showed a net clinical benefit for decision thresholds ranging from 0.2 to 0.8 in both datasets.
conclusionThe Borutamodel represents a promising tool for early risk assessment of PsA. Key Points • National Database Utilization: This study leverages the NHANES database to predict psoriatic arthritis risk, addressing previous limitations tied to regional or ethnic constraints. • Comprehensive Variable Analyses: The research examines 38 variables, including demographics, health conditions, laboratory results, and lifestyle factors, using four distinct screening methods and thorough evaluations of model performance. • Innovative Risk Model: The study introduces a novel risk assessment model that integrates age, fasting glucose, education, and comorbidities including hypertension, thyroid disease, and chronic bronchitis, thus moving beyond traditional focus on skin lesions and joint symptoms.
Indexed as
Identifiers
39585569What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.